MedPath

Personalised Prevention of Microbiological Homeostasis in the Oral Cavity During Fixed Orthodontic Treatment

Not Applicable
Not yet recruiting
Conditions
Orthodontics
Registration Number
NCT06752902
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

Oral dysbiosis systematically develops during orthodontic treatment \[35\]\[36\]. Orthodontic appliances interfere with oral hygiene procedures and cause biofilm to accumulate, creating new retention zones, even in subjects who maintain correct oral hygiene \[37\]:

* A group benefiting from intensive personalised prevention

* A "conventionally monitored" group, with no personalised prevention. The hypothesis is that personalised prevention prevents dysbiosis from taking hold. If this hypothesis is confirmed, the concept could be extended to all patients, beyond orthodontics.

Based on the "biological signature" (microbiological and immune), a "risk profile" of patients could be defined, making it possible to better personalise the prevention message, the method applied and the frequency of follow-up. The aim would be to rebalance dysbiosis through a personalised prevention approach tailored to the profile defined.

It was decided to explore this hypothesis initially with orthodontic patients because they are "captive", i.e. in the course of treatment requiring regular visits. Prevention is aimed first and foremost at healthy patients, with the aim of maintaining them in good health. The project focuses on young patients undergoing orthodontic treatment

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Patients aged 12 to 20 (permanent dentition) requiring fixed orthodontic treatment.
Exclusion Criteria
  • Tobacco;
  • Overcrowded restorations, untreated caries,
  • lack of tooth mineralisation;
  • Medical pathologies;
  • Known immunodepression (congenital or acquired);
  • Taking a treatment that may induce general immunodepression;
  • Taking a probiotic;
  • Taking a concomitant treatment that may interact with oral health

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
bacteria in biofilmAt 12 months

number of pathogenic bacteria measured in the biofilm

viruses in biofilmAt 12 months

number of viruses measured in the biofilm

Secondary Outcome Measures
NameTimeMethod
patient's satisfactionat 12 months

Patient satisfaction on a numerical scale from 0 to 10.

measurement of immune responseAt 12 months

assay of salivary cytokines in ng/ml

plaque indexthrough study completion, an average of 1 year

scale QHI: quigley hein index

gingival index,through study completion, an average of 1 year

gingival index mesured with Ginigical Index Loe\&Silness scale

toothbrush wearthrough study completion, an average of 1 year

toothbrush wear with the Toothbrush Wear Index (TWI)

Trial Locations

Locations (2)

Rance Orthodontics Practice

🇫🇷

Dinan, France

Nice university hospital

🇫🇷

Nice, France

© Copyright 2025. All Rights Reserved by MedPath